$58.77
1.89% today
NYSE, Sep 03, 10:00 pm CET
ISIN
US3795772082
Symbol
GMED

Globus Medical, Inc. Class A Stock price

$59.90
+6.27 11.69% 1M
-19.35 24.42% 6M
-22.81 27.58% YTD
-12.80 17.61% 1Y
+1.65 2.83% 3Y
+2.47 4.30% 5Y
+35.98 150.42% 10Y
+46.40 343.70% 20Y
NYSE, Closing price Tue, Sep 02 2025
-1.37 2.24%

Key metrics

Basic
Market capitalization
$8.1b
Enterprise Value
$7.9b
Net debt
positive
Cash
$229.5m
Shares outstanding
135.1m
Valuation (TTM | estimate)
P/E
23.0 | 18.3
P/S
3.1 | 2.8
EV/Sales
3.0 | 2.7
EV/FCF
15.0
P/B
1.9
Financial Health
Equity Ratio
79.5%
Return on Equity
2.5%
ROCE
11.3%
ROIC
10.6%
Debt/Equity
0.0
Financials (TTM | estimate)
Revenue
$2.6b | $2.9b
EBITDA
$630.6m | $839.0m
EBIT
$511.6m | $588.2m
Net Income
$356.7m | $441.8m
Free Cash Flow
$522.4m
Growth (TTM | estimate)
Revenue
17.4% | 15.6%
EBITDA
133.7% | 49.7%
EBIT
203.6% | 33.4%
Net Income
776.7% | 329.0%
Free Cash Flow
224.3%
Margin (TTM | estimate)
Gross
69.0%
EBITDA
24.0% | 28.8%
EBIT
19.5%
Net
13.6% | 15.2%
Free Cash Flow
19.9%
More
EPS
$2.6
FCF per Share
$3.9
Short interest
5.4%
Employees
5k
Rev per Employee
$480.0k
Show more

Is Globus Medical, Inc. Class A a Top Scorer Stock based on the Dividend, High-Growth-Investing or Leverman Strategy?

As a Free StocksGuide user, you can view scores for all 7,011 stocks worldwide.

Globus Medical, Inc. Class A Stock Analysis

Unlock Scores for Free

Analyst Opinions

21 Analysts have issued a Globus Medical, Inc. Class A forecast:

14x Buy
67%
7x Hold
33%

Analyst Opinions

21 Analysts have issued a Globus Medical, Inc. Class A forecast:

Buy
67%
Hold
33%

Financial data from Globus Medical, Inc. Class A

Income Statement P&L | Balance Sheet | Cash Flow


Quarter TTM Annually
Jun '25
+/-
%
2,626 2,626
17% 17%
100%
- Direct Costs 815 815
10% 10%
31%
1,812 1,812
36% 36%
69%
- Selling and Administrative Expenses 1,040 1,040
17% 17%
40%
- Research and Development Expense 141 141
20% 20%
5%
631 631
134% 134%
24%
- Depreciation and Amortization 119 119
17% 17%
5%
EBIT (Operating Income) EBIT 512 512
204% 204%
19%
Net Profit 357 357
777% 777%
14%

In millions USD.

Don't miss a Thing! We will send you all news about Globus Medical, Inc. Class A directly to your mailbox free of charge.

If you wish, we will send you an e-mail every morning with news on stocks of your portfolios.

Globus Medical, Inc. Class A Stock News

Neutral
GlobeNewsWire
6 days ago
AUDUBON, Pa., Aug. 28, 2025 (GLOBE NEWSWIRE) -- Globus Medical, Inc. (NYSE: GMED), a leading musculoskeletal technology company, announced that a Delaware jury has returned a verdict in favor of Globus in its patent infringement litigation against Life Spine, Inc.
Neutral
Seeking Alpha
26 days ago
Globus Medical, Inc. (NYSE:GMED ) Q2 2025 Earnings Conference Call August 7, 2025 4:30 PM ET Company Participants Brian J. Kearns - Senior Vice President of Business Development & Investor Relations David C.
Neutral
The Motley Fool
27 days ago
Globus Medical (GMED) Q2 Revenue Up 18%
More Globus Medical, Inc. Class A News

Company Profile

Globus Medical, Inc. operates as a medical device company that develops and commercializes healthcare solutions. The firm engages in developing products that promote healing in patients with musculoskeletal disorders. It classifies products into Innovative Fusion and Disruptive Technology. It operates through the United States and International geographical segments. The company was founded by David C. Paul, David D. Davidar and Andrew Iott in March 2003 and is headquartered in Audubon, PA.

Head office United States
CEO Daniel Scavilla
Employees 5,300
Founded 2003
Website www.globusmedical.com

Register for Free

StocksGuide is the ultimate tool for easily finding, analyzing and tracking stocks. Learn from successful investors and make informed investment decisions. We empower you to become a confident, independent investor.

The Apple stock at a glance with charts, current key metrics, news and stock analyses.
The Best Dividend Stocks in the Dividend Top Scorer list.
Stock Analyses of the Best Stocks Worldwide.
Start building wealth today